Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring

B. van Hilten, J. I. Hoff, H. A. Middelkoop, E. A. van der Velde, G. A. Kerkhof, A. Wauquier, H. A. Kamphuisen and R. A. Roos
Department of Neurology, Academic Hospital, Leiden, The Netherlands.

OBJECTIVE: To assess differences in activity and immobility during sleep between patients with Parkinson's disease (PD) and healthy subjects and to evaluate the relations of clinical variables with the motor activity measures in patients with PD. DESIGN: Survey, case series. SETTING: University hospital outpatient neurology department and urban population in Leiden, the Netherlands. Motor activity was recorded during 6 successive nights at home with a wrist-worn activity monitor. PARTICIPANTS: Eighty-nine patients with PD and 83 age-matched healthy controls. MAIN OUTCOME MEASURES: For each subject, three mean measures reflecting activity or immobility during the nocturnal period were calculated. RESULTS: Compared with the healthy elderly subjects, patients with PD have an elevated nocturnal activity level and an increased proportion of time with movement, indicating a more disturbed sleep. The mean duration of nocturnal immobility periods was similar for both groups. This measure, however, did reflect the self-reported disturbed sleep maintenance in both groups. The daily dose of levodopa or the use of dopamine agonists in patients not receiving levodopa, rather than disease severity, proved to be the best predictors of nocturnal activity. CONCLUSIONS: We hypothesize that in mildly to moderately affected patients with PD, levodopa or dopamine agonists cause sleep disruption by their effects on sleep regulation. In more severely affected patients, the beneficial effects of these drugs on nocturnal disabilities that cause sleep disruption in PD prevail.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk factors for somnolence, edema, and hallucinations in early Parkinson disease
Biglan et al.
Neurology 2007;69:187-195.
ABSTRACT | FULL TEXT  

Insomnia in Parkinson's disease: frequency and progression over time
Gjerstad et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:476-479.
ABSTRACT | FULL TEXT  

Present and future drug treatment for Parkinson's disease
Schapira
J. Neurol. Neurosurg. Psychiatry 2005;76:1472-1478.
ABSTRACT | FULL TEXT  

Nocturnal activity with nighttime pergolide in Parkinson disease: A controlled study using actigraphy
Comella et al.
Neurology 2005;64:1450-1451.
ABSTRACT | FULL TEXT  

Nocturnal problems occurring in Parkinson's disease
Grandas and Iranzo
Neurology 2004;63:S8-S11.
ABSTRACT | FULL TEXT  

Excessive daytime sleepiness in Parkinson's disease
Schapira
Neurology 2004;63:S24-S27.
FULL TEXT  

Restless legs syndrome and PD: A review of the evidence for a possible association
Garcia-Borreguero et al.
Neurology 2003;61:S49-55.
ABSTRACT | FULL TEXT  

Daytime sleepiness and other sleep disorders in Parkinson's disease
Ondo et al.
Neurology 2001;57:1392-1396.
ABSTRACT | FULL TEXT  

An algorithm (decision tree) for the management of Parkinson's disease (2001):: Treatment
Olanow et al.
Neurology 2001;56:S1-S88.
FULL TEXT